Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21972164 | 0.96 | CYP1B1 (0.34) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL21904612 | 0.95 | CYP1B1 (0.36) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL21972878 | 0.94 | CYP1B1 (0.35) | CYP1B1 | |
| SCHEMBL21972188 | 0.94 | CYP1B1 (0.35) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL25491295 | 0.93 | CYP1B1 (0.35) | CYP1B1 | |
| SCHEMBL21971943 | 0.90 | CYP1B1 (0.33) | CYP1B1 | |
| SCHEMBL21972880 | 0.90 | CYP1B1 (0.33) | CYP1B1 | |
| SCHEMBL21971940 | 0.90 | — | — | |
| SCHEMBL21971939 | 0.90 | CYP1B1 (0.34) | CYP1B1 | |
| SCHEMBL21971938 | 0.89 | CYP1B1 (0.33) | CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150988-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230150988-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20200140422-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140422-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CYP1A1, CYP1B1, CHRM1 | CYP1A2 16/4885ERBB2 3222/4885FYN 2854/4885 |
| US-20230150988-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CYP1A1, CYP1B1, CHRM1 | CYP1A2 16/4885ERBB2 3222/4885FYN 2854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.